by GlobeNewsWire | Aug 11, 2016 | Globe Newswire
IRVING, Texas, Aug. 11, 2016 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or “the Company”), a clinical stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2016 and provided an update...
by GlobeNewsWire | Aug 11, 2016 | Globe Newswire
GERMANTOWN, Md., Aug. 11, 2016 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, reported its financial results and provided...
by GlobeNewsWire | Aug 11, 2016 | Globe Newswire
VY-AADC01 Phase 1b Study for Advanced Parkinson’s Disease On Track to Report Six-Month Safety, Motor Function, and Biomarker Data from Cohorts 1 and 2 by Year-End 2016 Pipeline Advances with Selection of Lead Clinical Candidates for Multiple Pipeline Programs by Late...
by GlobeNewsWire | Aug 10, 2016 | Canadian Stocks, Globe Newswire
TORONTO, Aug. 10, 2016 (GLOBE NEWSWIRE) — Nevada Zinc Corporation (“Nevada Zinc” or the “Company”) (TSX-V:NZN) is very pleased to report the assay results from eight reverse circulation drill holes recently completed on the Company’s Lone Mountain zinc project...
by GlobeNewsWire | Aug 9, 2016 | Globe Newswire
CAMBRIDGE, Mass., Aug. 09, 2016 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today announced dosing of the first...